Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-266854
Filing Date
2025-11-05
Accepted
2025-11-05 16:02:31
Documents
92
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cprx-20250930.htm   iXBRL 10-Q 2605431
2 EX-31.1 cprx-ex31_1.htm EX-31.1 14689
3 EX-31.2 cprx-ex31_2.htm EX-31.2 14698
4 EX-32.1 cprx-ex32_1.htm EX-32.1 11193
5 EX-32.2 cprx-ex32_2.htm EX-32.2 11208
  Complete submission text file 0001193125-25-266854.txt   11709767

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cprx-20250930.xsd EX-101.SCH 1398942
95 EXTRACTED XBRL INSTANCE DOCUMENT cprx-20250930_htm.xml XML 2477991
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 251453773
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)